CellTrend offers new antibodies for Long-Covid patients. The PAR1 (thrombin receptor) antibody as a biomarker for thrombotic events (embolism, stroke, myocardial infarction), antibodies against the chemokine receptor CXCR3 and antibodies against the scavenger protein STABILIN-1 as risk parameters for cardiac events.
These 3 new biomarkers are now available on our request form!